INVO Fertility Operating Expenses 2010-2025 | IVF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

INVO Fertility operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

INVO Fertility operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$145.2B
CVS Health (CVS)	$74.3B
Elevance Health (ELV)	$63.1B
Cencora (COR)	$56.3B
DiDi Global (DIDIY)	$26.2B
Labcorp Holdings (LH)	$22.4B
Natera (NTRA)	$19.3B
BioMerieux (BMXMF)	$16B
ICON (ICLR)	$15.7B
EUROFINS SCIENT (ERFSF)	$14.8B
CochLear (CHEOY)	$13.4B
Medpace Holdings (MEDP)	$12.8B
Solventum (SOLV)	$12.8B
Revvity (RVTY)	$12B
Viatris (VTRS)	$11B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.3B
Charles River Laboratories (CRL)	$8.7B
HealthEquity (HQY)	$8.2B
Caris Life Sciences,�Inc (CAI)	$7.5B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.4B
Surgery Partners (SGRY)	$2.7B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.5B
GeneDx Holdings (WGS)	$2.3B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B